Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 17, 2003

View Archived Issues

Antimetastatic effects of a CXCR4 antagonist evaluated in vitro and in vivo in mice

Inhibitex and Texas A&M researchers claim SdrG-targeted antibodies as bacterial vaccines

New CDK inhibitors recently identified at Schering AG

Walter Reed Army Institute scientists prepare and test a novel antimalarial agent

Novel antibacterial carbapenems presented by Wyeth Lederle Japan researchers

Pfizer designs new alpha1L-adrenoceptor antagonists for BPH therapy

GSK team develops new calcitonin agonists with potential in bone disorders

Phase IIb trial of ATL-962 for obesity meets primary endpoint

Positive preliminary findings emerge from phase IIb trial of renzapride for mixed-symptom IBS

Phase III IND filed for interferon alfa lozenges for oral warts in HIV patients

SBIR grant supports GPCR efforts at Novasite

Third-quarter progress at Genzyme

ISTA updates pipeline progress

Quarterly highlights at Karo Bio

Positive data reported on AGT-MI for angiogenic therapy

Sunesis acquires exclusive rights to SPC-595

Orally active PDE5 inhibitor shows potential for use in pulmonary hypertension

Preclinical efficacy of the cannabinoid CB1 receptor antagonist SR-14176A in improving memory

Development and marketing agreement for Ventavis signed for U.S.

Potential role suggested for arginase inhibitors in the treatment of overactive bladder

A novel target described for the therapy of chronic cystitis

Endothelin receptors suggested as potential targets for overactive bladder

Stampidine as a potential nonspermicidal anti-HIV microbicide

Benefits reported for a menotropin/follitropin alfa combination in IVF

Effects of trimegestone/conjugated estrogens in postmenopausal women

Beneficial effects on cholesterol and adiposity for EM-652 in ovariectomized animals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...